{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:32:07Z","timestamp":1792650727188,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01HL147835"],"award-info":[{"award-number":["P01HL147835"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK119460"],"award-info":[{"award-number":["K23DK119460"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK120515"],"award-info":[{"award-number":["P30DK120515"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK106419"],"award-info":[{"award-number":["R01DK106419"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK121378"],"award-info":[{"award-number":["R01DK121378"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK124318"],"award-info":[{"award-number":["R01DK124318"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061734"],"award-info":[{"award-number":["U01DK061734"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["5P42ES010337"],"award-info":[{"award-number":["5P42ES010337"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["U01AA029019"],"award-info":[{"award-number":["U01AA029019"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5UL1TR001442"],"award-info":[{"award-number":["5UL1TR001442"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-2-0026"],"award-info":[{"award-number":["W81XWH-18-2-0026"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.molmet.2021.101167","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T02:40:56Z","timestamp":1610937656000},"page":"101167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":201,"special_numbering":"C","title":["Imaging biomarkers of NAFLD, NASH, and fibrosis"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5626-0942","authenticated-orcid":false,"given":"Veeral","family":"Ajmera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.molmet.2021.101167_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101167_bib2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101167_bib3","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101167_bib4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.molmet.2021.101167_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101167_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A\u00a0new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101167_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinologica"},{"issue":"Suppl s1","key":"10.1016\/j.molmet.2021.101167_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ajt.15674","article-title":"OPTN\/SRTR 2018 annual data report: liver","volume":"20","author":"Kwong","year":"2020","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1016\/j.molmet.2021.101167_bib9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101167_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","article-title":"Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study","volume":"71","author":"Haldar","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"11","key":"10.1016\/j.molmet.2021.101167_bib11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/apt.15679","article-title":"Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data","volume":"51","author":"Loomba","year":"2020","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"7","key":"10.1016\/j.molmet.2021.101167_bib12","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101167_bib13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/hep.21346","article-title":"Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease","volume":"44","author":"Merriman","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101167_bib14","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"issue":"1091","key":"10.1016\/j.molmet.2021.101167_bib15","doi-asserted-by":"crossref","first-page":"20170587","DOI":"10.1259\/bjr.20170587","article-title":"Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis","volume":"91","author":"Zhang","year":"2018","journal-title":"British Journal of Radiology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101167_bib16","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.26072","article-title":"Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?","volume":"57","author":"van der Poorten","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101167_bib17","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.2214\/AJR.07.2123","article-title":"Interobserver and intraobserver variability in the sonographic assessment of fatty liver","volume":"189","author":"Strauss","year":"2007","journal-title":"American Journal of Roentgenology"},{"issue":"7","key":"10.1016\/j.molmet.2021.101167_bib18","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.cgh.2014.11.027","article-title":"Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique","volume":"13","author":"Lin","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101167_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1148\/radiol.2020191152","article-title":"Assessment of hepatic steatosis in nonalcoholic fatty liver disease by using quantitative US","volume":"295","author":"Han","year":"2020","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101167_bib20","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101167_bib21","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.29639","article-title":"Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis","volume":"67","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2021.101167_bib22","article-title":"Optimal threshold of controlled attenuation parameter for detection of HIV-associated NAFLD with magnetic resonance imaging as the reference standard","author":"Ajmera","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1016\/j.molmet.2021.101167_bib23","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101167_bib24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jhep.2017.05.005","article-title":"Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter","volume":"67","author":"Wong","year":"2017","journal-title":"Journal of Hepatology"},{"issue":"8","key":"10.1016\/j.molmet.2021.101167_bib25","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.cgh.2019.11.060","article-title":"Prospective, same-day, direct comparison of controlled attenuation parameter with the M vs the XL probe in patients with nonalcoholic fatty liver disease, using magnetic resonance imaging\u2013proton density fat fraction as the standard","volume":"18","author":"Caussy","year":"2020","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101167_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jmri.22580","article-title":"Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy","volume":"34","author":"Reeder","year":"2011","journal-title":"Journal of Magnetic Resonance Imaging"},{"issue":"2","key":"10.1016\/j.molmet.2021.101167_bib27","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"American Journal of Physiology Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.molmet.2021.101167_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/apt.13405","article-title":"Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE","volume":"43","author":"Doycheva","year":"2016","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1016\/j.molmet.2021.101167_bib29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jhep.2016.06.005","article-title":"MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice","volume":"65","author":"Dulai","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101167_bib30","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/hep.27647","article-title":"Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)","volume":"61","author":"Loomba","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101167_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2036.2012.05121.x","article-title":"Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD","volume":"36","author":"Permutt","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1016\/j.molmet.2021.101167_bib32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1148\/radiol.14140754","article-title":"Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease","volume":"274","author":"Tang","year":"2015","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101167_bib33","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"152","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101167_bib34","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/jmri.22701","article-title":"Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms","volume":"34","author":"Kang","year":"2011","journal-title":"Journal of Magnetic Resonance Imaging"},{"issue":"6","key":"10.1016\/j.molmet.2021.101167_bib35","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/jmri.23928","article-title":"Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging","volume":"37","author":"Mashhood","year":"2013","journal-title":"Journal of Magnetic Resonance Imaging"},{"issue":"6","key":"10.1016\/j.molmet.2021.101167_bib36","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/hep.26455","article-title":"Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2021.101167_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31121","article-title":"Multicenter validation of association between decline in MRI-PDFF and histologic response in NASH","author":"Loomba","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101167_bib38","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography","volume":"150","author":"Imajo","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101167_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2018.04.014","article-title":"Magnetic resonance imaging proton density fat fraction associates with progression of fibrosis in patients with nonalcoholic fatty liver disease","volume":"155","author":"Ajmera","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101167_bib40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jhep.2016.04.021","article-title":"Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"65","author":"Cui","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101167_bib41","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.25731","article-title":"Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial","volume":"56","author":"Le","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101167_bib42","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","article-title":"Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2021.101167_bib43","article-title":"Change in MRI-PDFF and histologic response in patients with nonalcoholic steatohepatitis: a systematic review and meta-analysis","author":"Stine","year":"2020","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101167_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-0037-1618587","article-title":"Can elastography differentiate isolated fatty liver from nonalcoholic steatohepatitis?","volume":"38","author":"Ajmera","year":"2018","journal-title":"Seminars in Liver Disease"},{"key":"10.1016\/j.molmet.2021.101167_bib45","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/liv.13284","article-title":"Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity","author":"Pavlides","year":"2017","journal-title":"Liver International"},{"key":"10.1016\/j.molmet.2021.101167_bib46","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14625","article-title":"Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease","author":"Jayaswal","year":"2020","journal-title":"Liver International"},{"issue":"6","key":"10.1016\/j.molmet.2021.101167_bib47","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.27362","article-title":"Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study","volume":"60","author":"Loomba","year":"2014","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.molmet.2021.101167_bib48","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ajg.2016.65","article-title":"Novel 3D magnetic resonance elastography for the noninvasive diagnosis of advanced fibrosis in NAFLD: a prospective study","volume":"111","author":"Loomba","year":"2016","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101167_bib49","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/hep.30483","article-title":"The role of three-dimensional magnetic resonance elastography in the diagnosis of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery","volume":"71","author":"Allen","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101167_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157358","article-title":"Discrimination of nonalcoholic steatohepatitis using transient elastography in patients with nonalcoholic fatty liver disease","volume":"11","author":"Lee","year":"2016","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.molmet.2021.101167_bib51","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.28394","article-title":"Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy","volume":"63","author":"Cassinotto","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101167_bib52","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.29179","article-title":"Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis","volume":"67","author":"Herrmann","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.molmet.2021.101167_bib53","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/ajg.2012.331","article-title":"Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease","volume":"107","author":"Wong","year":"2012","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101167_bib54","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.23425","article-title":"Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations","volume":"51","author":"Castera","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101167_bib55","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101167_bib56","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cgh.2018.05.059","article-title":"Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants","volume":"17","author":"Hsu","year":"2019","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101167_bib57","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1148\/radiol.2016160863","article-title":"Technical failure of MR elastography examinations of the liver: experience from a large single-center study","volume":"284","author":"Wagner","year":"2017","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101167_bib58","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00330-015-3949-z","article-title":"Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis","volume":"26","author":"Singh","year":"2016","journal-title":"European Radiology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101167_bib59","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cgh.2014.09.046","article-title":"Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data","volume":"13","author":"Singh","year":"2015","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101167_bib60","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1148\/radiol.2016160685","article-title":"Diagnostic performance of MR elastography and vibration-controlled transient elastography in the detection of hepatic fibrosis in patients with severe to morbid obesity","volume":"283","author":"Chen","year":"2017","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.molmet.2021.101167_bib61","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.cgh.2020.04.017","article-title":"Cost effectiveness of different strategies for detecting cirrhosis in patients with nonalcoholic fatty liver disease based on United States health care system","volume":"18","author":"Vilar-Gomez","year":"2020","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101167_bib62","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterology and Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101167_bib63","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/apt.14219","article-title":"Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD","volume":"46","author":"Petta","year":"2017","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1016\/j.molmet.2021.101167_bib64","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/liv.14301","article-title":"Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver disease","volume":"40","author":"Shili-Masmoudi","year":"2020","journal-title":"Liver International"},{"key":"10.1016\/j.molmet.2021.101167_bib65","article-title":"Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease","author":"Petta","year":"2020","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"9","key":"10.1016\/j.molmet.2021.101167_bib66","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1111\/liv.14593","article-title":"MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: a multicenter study","volume":"40","author":"Han","year":"2020","journal-title":"Liver International"},{"key":"10.1016\/j.molmet.2021.101167_bib67","article-title":"Liver stiffness by magnetic resonance elastography predicts future cirrhosis, decompensation and death in NAFLD","author":"Gidener","year":"2020","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101167_bib68","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhep.2018.09.024","article-title":"Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: analysis of data from a phase II trial of selonsertib","volume":"70","author":"Jayakumar","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101167_bib69","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/hep.30974","article-title":"Clinical utility of an increase in magnetic resonance elastography in predicting fibrosis progression in nonalcoholic fatty liver disease","volume":"71","author":"Ajmera","year":"2020","journal-title":"Hepatology"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821000077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821000077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:25:15Z","timestamp":1761956715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877821000077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":69,"alternative-id":["S2212877821000077"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101167","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging biomarkers of NAFLD, NASH, and fibrosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101167"}}